Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

By P. Speiser, W. Arlt, R. Auchus, L. Baskin, G. Conway, D. Merke, H. Meyer-Bahlburg, W. Miller, M. Murad, S. Oberfield and 1 more. Journal of Clinical Endocrinology and Metabolism, 2018

700 citations recorded by the source corpus.

Objective To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010. Conclusions The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.

Subfields: Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/8068e1a538476052b7d15499212a9361af26ce3e